Continue to site >
Trending ETFs

BlackRock Funds IV - BlackRock Health Sciencs Oppor Port Fd USD Cls R

mutual fund
BHSRX
Payout Change
Suspended
Price as of:
$68.81 +0.84 +1.24%
primary theme
Health Care Sector Equity
share class
BHSRX (Mutual Fund)

BlackRock Funds IV - BlackRock Health Sciencs Oppor Port Fd USD Cls R

Payout Change
Suspended
Price as of:
$68.81 +0.84 +1.24%
primary theme
Health Care Sector Equity
share class
BHSRX (Mutual Fund)

BlackRock Funds IV - BlackRock Health Sciencs Oppor Port Fd USD Cls R

Payout Change
Suspended
Price as of:
$68.81 +0.84 +1.24%
primary theme
Health Care Sector Equity
share class

Name

As of 03/27/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$68.81

$9.49 B

0.00%

$0.00

1.44%

Vitals

YTD Return

8.6%

1 yr return

17.4%

3 Yr Avg Return

5.4%

5 Yr Avg Return

10.1%

Net Assets

$9.49 B

Holdings in Top 10

41.5%

52 WEEK LOW AND HIGH

$68.0
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 1.44%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 19.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

$100

IRA

N/A


Fund Classification

Fund Type

Open End Mutual Fund


Name

As of 03/27/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$68.81

$9.49 B

0.00%

$0.00

1.44%

BHSRX - Profile

Distributions

  • YTD Total Return 8.6%
  • 3 Yr Annualized Total Return 5.4%
  • 5 Yr Annualized Total Return 10.1%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.37%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    BlackRock Funds IV - BlackRock Health Sciencs Oppor Port Fd USD Cls R
  • Fund Family Name
    BlackRock
  • Inception Date
    Sep 12, 2011
  • Shares Outstanding
    N/A
  • Share Class
    Other
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Erin Xie

Fund Description


BHSRX - Performance

Return Ranking - Trailing

Period BHSRX Return Category Return Low Category Return High Rank in Category (%)
YTD 8.6% -13.0% 22.1% 37.42%
1 Yr 17.4% -19.6% 37.7% 43.56%
3 Yr 5.4%* -30.2% 13.9% 35.26%
5 Yr 10.1%* -2.8% 14.5% 30.15%
10 Yr 10.2%* 0.3% 14.3% 32.71%

* Annualized

Return Ranking - Calendar

Period BHSRX Return Category Return Low Category Return High Rank in Category (%)
2023 -0.6% -12.6% 19.0% 72.39%
2022 -13.1% -53.9% 3.2% 55.13%
2021 1.8% -39.6% 24.2% 41.03%
2020 14.2% -13.6% 178.2% 49.01%
2019 20.2% 3.8% 63.8% 56.30%

Total Return Ranking - Trailing

Period BHSRX Return Category Return Low Category Return High Rank in Category (%)
YTD 8.6% -13.0% 22.1% 37.42%
1 Yr 17.4% -19.6% 37.7% 43.56%
3 Yr 5.4%* -30.2% 13.9% 35.26%
5 Yr 10.1%* -2.8% 14.5% 30.15%
10 Yr 10.2%* 0.3% 14.3% 32.71%

* Annualized

Total Return Ranking - Calendar

Period BHSRX Return Category Return Low Category Return High Rank in Category (%)
2023 3.2% -12.6% 19.0% 66.87%
2022 -6.3% -53.9% 3.7% 28.85%
2021 11.4% -33.9% 26.0% 39.10%
2020 19.1% -0.7% 180.6% 62.25%
2019 24.9% 4.6% 63.8% 58.52%

NAV & Total Return History


BHSRX - Holdings

Concentration Analysis

BHSRX Category Low Category High BHSRX % Rank
Net Assets 9.49 B 6.16 M 45 B 5.52%
Number of Holdings 150 23 413 9.82%
Net Assets in Top 10 4.17 B 2.07 M 20.4 B 6.75%
Weighting of Top 10 41.45% 18.1% 77.0% 80.98%

Top 10 Holdings

  1. UnitedHealth Group Inc 9.44%
  2. Johnson & Johnson 4.46%
  3. Eli Lilly and Co 4.02%
  4. Thermo Fisher Scientific Inc 3.94%
  5. Pfizer Inc 3.79%
  6. Abbott Laboratories 3.45%
  7. AbbVie Inc 3.26%
  8. Cigna Corp 3.09%
  9. Danaher Corp 3.05%
  10. Medtronic PLC 2.98%

Asset Allocation

Weighting Return Low Return High BHSRX % Rank
Stocks
96.90% 87.17% 106.13% 59.51%
Cash
2.30% 0.00% 32.99% 47.85%
Other
0.80% -22.99% 17.73% 16.56%
Preferred Stocks
0.00% 0.00% 7.86% 95.09%
Convertible Bonds
0.00% 0.00% 0.37% 94.30%
Bonds
0.00% 0.00% 12.39% 100.00%

Stock Sector Breakdown

Weighting Return Low Return High BHSRX % Rank
Healthcare
98.96% 59.26% 100.00% 79.75%
Basic Materials
0.73% 0.00% 7.16% 19.62%
Financial Services
0.31% 0.00% 1.60% 10.13%
Utilities
0.00% 0.00% 0.00% 93.04%
Technology
0.00% 0.00% 22.69% 94.94%
Real Estate
0.00% 0.00% 5.89% 93.67%
Industrials
0.00% 0.00% 7.02% 94.30%
Energy
0.00% 0.00% 0.00% 93.04%
Communication Services
0.00% 0.00% 9.11% 93.04%
Consumer Defense
0.00% 0.00% 25.73% 93.67%
Consumer Cyclical
0.00% 0.00% 1.92% 93.04%

Stock Geographic Breakdown

Weighting Return Low Return High BHSRX % Rank
US
90.61% 66.21% 104.41% 60.12%
Non US
6.29% 0.00% 29.78% 38.65%

BHSRX - Expenses

Operational Fees

BHSRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.44% 0.08% 4.28% 33.13%
Management Fee 0.67% 0.03% 1.25% 49.08%
12b-1 Fee 0.50% 0.00% 1.00% 70.51%
Administrative Fee 0.07% 0.03% 0.25% 23.68%

Sales Fees

BHSRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

BHSRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 1.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

BHSRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 19.00% 0.00% 238.00% 18.12%

BHSRX - Distributions

Dividend Yield Analysis

BHSRX Category Low Category High BHSRX % Rank
Dividend Yield 0.00% 0.00% 6.97% 100.00%

Dividend Distribution Analysis

BHSRX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Annual Annual

Net Income Ratio Analysis

BHSRX Category Low Category High BHSRX % Rank
Net Income Ratio -0.37% -2.54% 1.85% 63.46%

Capital Gain Distribution Analysis

BHSRX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

Distributions History

View More +

BHSRX - Fund Manager Analysis

Managers

Erin Xie


Start Date

Tenure

Tenure Rank

Jul 31, 2003

18.85

18.9%

Ms. Xie is the managing director and Portfolio Manager of BlackRock Advisor since 2006. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Ms. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.

Xiang Liu


Start Date

Tenure

Tenure Rank

Jun 01, 2020

2.0

2.0%

Director of BlackRock since 2016. Prior to joining BlackRock in 2008, Mr. Liu was a Partner and Biotech Analyst at Mehta Partners. Mr. Liu began his investment career in 2000 and has a BS from the University of Science & Technology (China), an MBA from the University of Chicago and a PhD degree in Chemistry from Yale University.

Jeff Lee


Start Date

Tenure

Tenure Rank

Jun 01, 2020

2.0

2.0%

Director of BlackRock since 2011. Mr. Lee began his investment career in 2006 and has a BA from Princeton University

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 7.84 0.25